LEP and systemic sclerosis: Subsequent proinflammatory cytokines (type I interferons, TGF-β, interleukin 17, and interleukin 23) and mediators (leptin, adiponectin, chimerin, and interleukin 6) would promote the pathogenesis of SSc [21].